A bill to eliminate the requirement that veterans pay a copayment to the Department of Veterans Affairs to receive opioid antagonists or education on the use of opioid antagonists.

Hozzl · 2023-01-11T13:31:26Z

Explore the details of Senate Bill 2772 A bill to eliminate the requirement that veterans pay a copayment to the Department of Veterans Affairs to receive opioid antagonists or education on the use of opioid antagonists. currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Armed Forces and National Security. Stay informed on legislative developments.

1/11/2023, 1:31 PM

Congressional Summary of S 2772

This bill exempts from the requirement that veterans pay a Department of Veterans Affairs copayment for:

any opioid antagonists furnished to a veteran at high risk for overdose of a specific medication or substance in order to reverse the effect of such an overdose, and
education on their use.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill S 2772

Bill S 2772 is currently in the status of Bill Introduced since April 11, 2016. Bill S 2772 was introduced during Congress 114 and was introduced to the Senate on April 11, 2016. Bill S 2772's most recent activity was Read twice and referred to the Committee on Veterans' Affairs. as of April 11, 2016

Bipartisan Support of Bill S 2772

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill S 2772

Primary Policy Focus

Armed Forces and National Security

Potential Impact Areas

- Drug therapy

- Drug trafficking and controlled substances

- Health promotion and preventive care

- Home and outpatient care

- Veterans' medical care

Alternate Title(s) of Bill S 2772

A bill to eliminate the requirement that veterans pay a copayment to the Department of Veterans Affairs to receive opioid antagonists or education on the use of opioid antagonists.